Fig. 1From: Efficacy and safety of fixed dose combination of Sitagliptin, metformin, and pioglitazone in type 2 Diabetes (IMPACT study): a randomized controlled trialDisposition of study participants. AE, adverse events; FDC, fixed-dose combination; ITT, intention-to-treat; SAE, severe adverse effects; SR, sustained-releaseBack to article page